CORC

在结果中检索

CORC

浏览/检索结果: 共249条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Design of suppressing optical and recombination losses in ultrathin CuInGaSe2 solar cells by Voronoi nanocavity arrays 会议论文
作者:  Wang, Yi-Chung;  Chen, Chia-Wei;  Su, Teng-Yu;  Yang, Tzu-Yi;  Liu, Wen-Wu
收藏  |  浏览/下载：13/0  |  提交时间：2020/12/18
Research and application of spectral reconstruction technology based on periodic structure 会议论文
Xiamen, China, 2020-08-25
作者:  Liu, Bin;  Wei, Ru Yi;  Shi, Yi Shi;  Shi, Lei;  Zhang, Zai Kun
收藏  |  浏览/下载：15/0  |  提交时间：2020/12/29
Simulation study on liquid-end of high-pressure and large-flow-rate reciprocating pump 会议论文
Wuhan, China, April 10, 2019 - April 13, 2019
作者:  Ran, Li;  Wei, Wenshu;  Hao, Liu;  Yi, Zhu;  Hong, Ji
收藏  |  浏览/下载：1/0  |  提交时间：2020/11/15
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：140/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05
A Game-Theoretic Model for ADN Hierarchical Planning Considering Multi-interests Coordination of "Source-Network-Load" 会议论文
作者:  Zheng, Jie-Yun;  Zhang, Lin-Yao;  Lin, Chang-Zhui;  Ning, Yue;  Hu, Zhi-Jian
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace